Recent Reports on Fluid Therapy for Terminally Ill Cancer Patients and Indicators of Quality of Life

DOI Web Site Web Site 13 References
  • Sugiyama Mio
    Department of Pharmaceutical Service, Nippon Medical School Hospital
  • Ise Yuya
    Department of Pharmaceutical Service, Nippon Medical School Hospital
  • Katayama Shirou
    Department of Pharmaceutical Service, Nippon Medical School Hospital

Bibliographic Information

Other Title
  • がん医療と緩和ケア（7）
  • がん医療と緩和ケア(7)終末期がん患者における輸液治療の現状とQOL指標
  • ガン イリョウ ト カンワ ケア(7)シュウマツキ ガン カンジャ ニ オケル ユエキ チリョウ ノ ゲンジョウ ト QOL シヒョウ
  • 終末期がん患者における輸液治療の現状とQOL指標

Search this article

Abstract

Terminal cancer patients gradually reduce their oral intake, which can lead to cachexia and metabolic abnormalities. According to Japanese Society of Palliative Medicine guidelines, patients should reduce their fluid intake from one month before projected death. The effectiveness of fluid therapy in these patients should be evaluated by assessing their quality of life (QOL), and not only on the basis of physical symptoms. However, no specific QOL indicators are set out in the guidelines. We have reviewed recent reports on fluid therapy in terminally ill cancer patient in an attempt to identify appropriate indicators of QOL in palliative medicine.

Journal

References(13)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top